Market Overview

Endocyte Shares Up 48% Premarket; Following 157% Rally On Mon. Amid News Of Global License For PSMA-617, Shares Rose 20% After Hours; Wedbush Upgrade Tues. Morning Pushed Stock Up Another ~15%

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for ECYT

DateFirmActionFromTo
Jul 2018WedbushMaintainsOutperformOutperform
Apr 2018JefferiesInitiates Coverage OnBuy
Mar 2018Wells FargoInitiates Coverage OnOutperform

View More Analyst Ratings for ECYT
View the Latest Analyst Ratings

Posted-In: News Upgrades Pre-Market Outlook Analyst Ratings Movers Trading Ideas

 

Related Articles (ECYT)

Wall Street's M&A Chatter From October 2: CenturyLink-Level 3, Unilever-Mae Terras, Dimension-Ultragenyx

Disney, Gardner Denver, Intel: Fast Money Picks For October 3